Combined Cardiopulmonary Failure in COPD: SPIROMICS HF
Combined Cardiopulmonary Failure in COPD: SPIROMICS HF
批准号:
10656151
负责人:
R Graham BARR
金额:
$197.17万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-28 至 2024-06-30
关键词:
AdultAffectApicalBlood VesselsBlood flowCardiacCardiac OutputCardiopulmonaryChronic Obstructive Pulmonary DiseaseCodeComplexDRD1 geneDeath RateDevelopmental GeneDiffuseDimensionsDopamineEFRACEchocardiographyEndotheliumExerciseFGF10 geneFailureFibrosisFunctional disorderFundingGasesGenesHeartHeart AtriumHeart failureHospitalizationImpairmentKineticsLungLung CAT ScanMachine LearningMagnetic Resonance ImagingMapsMeasuresMechanicsMethodsMolecularMulti-Ethnic Study of AtherosclerosisMyocardialNational Heart, Lung, and Blood InstituteOutcome MeasureParticipantPathologyPatientsPhenotypeProspective StudiesPulmonary EmphysemaPulmonary FibrosisPulmonary Heart DiseaseRARA geneRight Ventricular HypertrophyRight ventricular strainRight ventricular structureSamplingSmokerStructureTechnologyTestingVariantVentricularWorkcardiogenesiscohortdisorder subtypegenetic variantheart functionheart preservationindexinginnovationinterstitiallung hypoxianovelnovel diagnosticsnovel therapeutic interventionpatient subsetspersonalized approachpersonalized diagnosticspersonalized medicinepilot testpreservationpulmonary arterial pressurepulmonary vasoconstrictionreceptorrecruittargeted treatmentunsupervised learning
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The death rate and hospitalizations from chronic obstructive pulmonary disease (COPD) have doubled in the
last 50 years. A third of COPD hospitalizations overlap with heart failure, mostly with preserved ejection
fraction (HFpEF), yet no large COPD study has ascertained cardiac function. The Multi-Ethnic Study of
Atherosclerosis (MESA) COPD Study was funded to test the endothelial hypothesis of emphysema and
examine reduced RV dimensions (“cor pulmonale parvus”) in COPD. In the MESA COPD Study II, we found
that associations of reduced pulmonary microvascular blood flow with emphysema do not appear to be
confounded by hypoxic pulmonary vasoconstriction and that emphysema on CT predicted RV regression over
5 years. We also developed methods to further subtype emphysema and COPD and scaled them up to the
SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS). We used unsupervised
machine learning to discover new emphysema subtypes that are common and have molecular origins.
Separately, we found that 26% of adults have segmental airway variants, which are associated with COPD and
the developmental genes FGF10 and RARA. Both genes affect right heart development. In pilot work, we
found one dramatically altered RV strain and the other associated with cor pulmonale parvus. Finally, we
found that bronchitic ‘symptomatic smokers,’ who have hyperinflation from gas trapping, may have increased
LV diastolic dysfunction. Hence, cardiac alterations in COPD are complex but recent advances in COPD
subtyping may allow their personalized diagnosis and treatment. SPIROMICS is an NHLBI-funded prospective
study that recruited smokers with COPD and controls and is re-examining 2,000 participants with gold-
standard lung phenotyping including full-lung CT. We propose to add comprehensive echocardiography (echo)
with speckle-tracking for cardiac mechanics for 1,000 SPIROMICS participants, with exercise in 700 and
cardiopulmonary MRI in 600, to test the following hypotheses: 1) machine-learned subtypes of emphysema on
CT are associated with specific alterations in cardiac structure and function, which vary from cor pulmonale to
LV diastolic dysfunction; 2) participants with segmental airway variants have abnormal RV structure and
function; 3) symptomatic smokers have signs of increased LV afterload and LV diastolic dysfunction.
Innovative aspects of the application include the use of novel echo and MRI measures in a large, well-
characterized cohort of COPD patients. Confirmation of the hypotheses would define the mechanisms of
HFpEF in COPD and identify subsets of patients for targeted treatment of cardiopulmonary dysfunction.
期刊论文(68)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.rmed.2018.06.001
发表时间:
2018-07
期刊:
Respiratory medicine
影响因子:
4.3
作者:
[Madahar P, Duprez DA, Podolanczuk AJ, Bernstein EJ, Kawut SM, Raghu G, Barr RG, Gross MD, Jacobs DR Jr, Lederer DJ]
通讯作者:
Lederer DJ
Emphysema Quantification on Cardiac CT Scans Using Hidden Markov Measure Field Model: The MESA Lung Study.
使用隐马尔可夫测量场模型对心脏 CT 扫描进行肺气肿定量:MESA 肺研究。
DOI:
10.1007/978-3-319-46723-8_72
发表时间:
2016
期刊:
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention
影响因子:
--
作者:
[Yang,Jie, Angelini,ElsaD, Balte,PallaviP, Hoffman,EricA, Wu,ColinO, Venkatesh,BharathA, Barr,RGraham, Laine,AndrewF]
通讯作者:
Laine,AndrewF
GENERATIVE METHOD TO DISCOVER EMPHYSEMA SUBTYPES WITH UNSUPERVISED LEARNING USING LUNG MACROSCOPIC PATTERNS (LMPS): THE MESA COPD STUDY.
使用肺宏观模式 (LMPS) 通过无监督学习发现肺气肿亚型的生成方法:MESA COPD 研究。
DOI:
10.1109/isbi.2017.7950541
发表时间:
2017
期刊:
Proceedings. IEEE International Symposium on Biomedical Imaging
影响因子:
--
作者:
[Song,Jingkuan, Yang,Jie, Smith,Benjamin, Balte,Pallavi, Hoffman,EricA, Barr,RGraham, Laine,AndrewF, Angelini,ElsaD]
通讯作者:
Angelini,ElsaD
DOI:
10.1371/journal.pone.0050224
发表时间:
2012
期刊:
PloS one
影响因子:
3.7
作者:
[Harris B, Klein R, Jerosch-Herold M, Hoffman EA, Ahmed FS, Jacobs DR Jr, Klein BE, Wong TY, Lima JA, Cotch MF, Barr RG]
通讯作者:
Barr RG
DOI:
10.3109/15412555.2011.558543
发表时间:
2011-04
期刊:
COPD
影响因子:
2.2
作者:
[McAllister DA, MacNee W, Duprez D, Hoffman EA, Vogel-Claussen J, Criqui MH, Budoff M, Jiang R, Bluemke DA, Barr RG]
通讯作者:
Barr RG
共 35 条
Training Program in Population Science of Respiratory Diseases
-
批准号:10469316
-
项目类别:
-
资助金额:$8.08万
-
财政年份:2019
-
负责人:R Graham BARR
-
依托单位:
Training Program in Population Science of Respiratory Diseases
-
批准号:10206247
-
项目类别:
-
资助金额:$8.92万
-
财政年份:2019
-
负责人:R Graham BARR
-
依托单位:
Training Program in Population Science of Respiratory Diseases
-
批准号:10671638
-
项目类别:
-
资助金额:$19.26万
-
财政年份:2019
-
负责人:R Graham BARR
-
依托单位:
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
-
批准号:10225220
-
项目类别:
-
资助金额:$80.63万
-
财政年份:2014
-
负责人:R Graham BARR
-
依托单位:
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
-
批准号:8894583
-
项目类别:
-
资助金额:$43.36万
-
财政年份:2014
-
负责人:R Graham BARR
-
依托单位:
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
-
批准号:10160645
-
项目类别:
-
资助金额:$73.03万
-
财政年份:2014
-
负责人:R Graham BARR
-
依托单位:
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
-
批准号:9927683
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2014
-
负责人:R Graham BARR
-
依托单位:
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
-
批准号:10453736
-
项目类别:
-
资助金额:$72.83万
-
财政年份:2014
-
负责人:R Graham BARR
-
依托单位:
Novel Quantitative Emphysema Subtypes in MESA and SPIROMICS
-
批准号:8759952
-
项目类别:
-
资助金额:$45.59万
-
财政年份:2014
-
负责人:R Graham BARR
-
依托单位:
HDL cholesterol and chronic lower respiratory disease events in five cohorts
-
批准号:8735184
-
项目类别:
-
资助金额:$11.76万
-
财政年份:2013
-
负责人:R Graham BARR
-
依托单位:
HDL cholesterol and chronic lower respiratory disease events in five cohorts
-
批准号:8624969
-
项目类别:
-
资助金额:$11.42万
-
财政年份:2013
-
负责人:R Graham BARR
-
依托单位:
Genome-wide and Linkage Study of Quantitative Emphysema Phenotypes
-
批准号:7833115
-
项目类别:
-
资助金额:$49.99万
-
财政年份:2009
-
负责人:R Graham BARR
-
依托单位:
Genome-wide and Linkage Study of Quantitative Emphysema Phenotypes
-
批准号:7935319
-
项目类别:
-
资助金额:$47.06万
-
财政年份:2009
-
负责人:R Graham BARR
-
依托单位:
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary Disease (COPD)
-
批准号:7895734
-
项目类别:
-
资助金额:$75.51万
-
财政年份:2008
-
负责人:R Graham BARR
-
依托单位:
Pulmonary Microvascular Blood Flow and Cor Pulmonale Parvus in Emphysema/COPD
-
批准号:8794453
-
项目类别:
-
资助金额:$74.66万
-
财政年份:2008
-
负责人:R Graham BARR
-
依托单位:
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary Disease (COPD)
-
批准号:8126218
-
项目类别:
-
资助金额:$78.54万
-
财政年份:2008
-
负责人:R Graham BARR
-
依托单位:
Pulmonary Microvascular Blood Flow and Cor Pulmonale Parvus in Emphysema/COPD
-
批准号:8998971
-
项目类别:
-
资助金额:$77.86万
-
财政年份:2008
-
负责人:R Graham BARR
-
依托单位:
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary Disease (COPD)
-
批准号:7682968
-
项目类别:
-
资助金额:$72.24万
-
财政年份:2008
-
负责人:R Graham BARR
-
依托单位:
Combined Cardiopulmonary Failure in COPD: SPIROMICS HF
-
批准号:10020427
-
项目类别:
-
资助金额:$233.13万
-
财政年份:2008
-
负责人:R Graham BARR
-
依托单位:
Pulmonary Microvascular Blood Flow and Cor Pulmonale Parvus in Emphysema/COPD
-
批准号:9212177
-
项目类别:
-
资助金额:$69.66万
-
财政年份:2008
-
负责人:R Graham BARR
-
依托单位:
海外基金